Should access to GLP-1 weight-loss drugs be publicly reimbursed?
14 votes|10 arguments|0 source
36%5
·
These drugs cost thousands per patient per year. Public budgets can't sustain mass prescriptions when lifestyle programs are cheaper. @@no_1
Safety surveillance of mRNA COVID-19 vaccines: 3-year follow-up
Research Paper·nejm.org
Pooled safety data from national registries covering ~600 million doses across Europe, North America and Israel.
Added by @ada
GLP-1 agonists: efficacy, cost-effectiveness, and equity
Article·bmj.com
Systematic review of semaglutide and tirzepatide trials and a cost-effectiveness model for public reimbursement.
Added by @lin
Pollution de l'air et mortalité en France
Report·santepubliquefrance.fr
Estimation annuelle de la mortalité attribuable aux particules fines (PM2.5) à l'échelle des aires urbaines.
Added by @claire